Bluejay Diagnostics, Inc.
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Acton, MA
BJDX chart
What traders are saying about $BJDX
Latest postsBluejay Diagnostics, Inc. news
- Bluejay Diagnostics, Inc. Estimates – NASDAQ:BJDX
TradingView ·
- Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness
Yahoo Finance ·
- Bluejay Diagnostics Advances Rapid Biomarker Testing For Sepsis Patients
Yahoo Finance ·
- Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock
Yahoo Finance ·
- Bluejay Diagnostics Federal Healthcare Partnership Builds Commercial Pathway Ahead of FDA Clearance
investorshub.advfn.com ·
- Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
Yahoo Finance ·
- Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
Yahoo Finance ·
- Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
Yahoo Finance ·
- Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Yahoo Finance ·
- Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Yahoo Finance ·
- Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership
Yahoo Finance ·
- Bluejay Diagnostics Provides First Quarter 2026 Corporate Update
Yahoo Finance ·
Bluejay Diagnostics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | $249,040 |
| Net income | -$6.8M | -$7.7M | -$10.0M | -$9.3M |
| Diluted EPS | $-15.25 | $-456.75 | $-3631.48 | $-9.22 |
| Total assets (year end) | $7.1M | $6.7M | $4.9M | $13.5M |
| Cash and equivalents (year end) | $5.2M | $4.3M | $2.2M | $10.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Bluejay Diagnostics, Inc.
- Ticker
- BJDX (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Acton, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1704287
Frequently asked questions
What exchange is Bluejay Diagnostics, Inc. listed on?
Bluejay Diagnostics, Inc. trades on the Nasdaq under the ticker symbol BJDX.
What industry is Bluejay Diagnostics, Inc. in?
Bluejay Diagnostics, Inc. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is Bluejay Diagnostics, Inc. headquartered?
Bluejay Diagnostics, Inc.'s business address on file with the SEC is in Acton, MA.
When does Bluejay Diagnostics, Inc.'s fiscal year end?
Bluejay Diagnostics, Inc.'s fiscal year ends on December 31.
How much revenue did Bluejay Diagnostics, Inc. report?
Bluejay Diagnostics, Inc. reported $249,040 in revenue for calendar year 2022, according to its SEC filings.